UNASSIGNED: Thirty three patients who had chronic schizophrenia were included in the study. Seventeen patients received rTMS and 16 received sham. The Positive and Negative Syndrome Scale, Repeatable Battery for the Assessment of Neuropsychological Status Scale, Insight and Treatment Attitudes Questionnaire and a self-experience checklist developed by the researchers to evaluate post-TMS experiences were applied to all patients.
UNASSIGNED: There were no statistical differences between the groups with regard to symptoms, cognitive functions and insight. However rTMS group reported overall better treatment experience and more positive subjective experiences.
UNASSIGNED: rTMS treatment did not cause any improvement in symptoms, cognitive functions and insight but provided a better self-experience, which might improve treatment compliance.
■33名患有慢性精神分裂症的患者被纳入研究。17名患者接受rTMS,16名患者接受假手术。阳性和阴性综合征量表,神经心理学状态量表评估的可重复电池,洞察力和治疗态度问卷和研究人员开发的自我经验清单,以评估TMS后的经验,适用于所有患者。
■两组在症状方面没有统计学差异,认知功能和洞察力。然而,rTMS组报告了总体更好的治疗经验和更积极的主观经验。
■rTMS治疗没有引起症状的任何改善,认知功能和洞察力,但提供了更好的自我体验,这可能会提高治疗依从性。